Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients
H Rincon-Arevalo, M Choi, AL Stefanski, F Halleck… - Science …, 2021 - science.org
Patients with kidney failure are at increased risk of SARS-CoV-2 infection, making effective
vaccinations a critical need. It is not known how well mRNA vaccines induce B and plasma …
vaccinations a critical need. It is not known how well mRNA vaccines induce B and plasma …
[HTML][HTML] Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination–specific humoral and cellular immunity in kidney transplant recipients
E Schrezenmeier, H Rincon-Arevalo, A Jens… - JCI insight, 2022 - ncbi.nlm.nih.gov
Transplant recipients exhibit an impaired protective immunity after SARS-CoV-2 vaccination,
potentially caused by mycophenolate (MPA) immunosuppression. Recent data from …
potentially caused by mycophenolate (MPA) immunosuppression. Recent data from …
B Cell Numbers Predict Humoral and Cellular Response Upon SARS–CoV‐2 Vaccination Among Patients Treated With Rituximab
AL Stefanski, H Rincon‐Arevalo… - Arthritis & …, 2022 - Wiley Online Library
Objective Patients with autoimmune inflammatory rheumatic diseases receiving rituximab (RTX)
therapy are at higher risk of poor COVID‐19 outcomes and show substantially impaired …
therapy are at higher risk of poor COVID‐19 outcomes and show substantially impaired …
B and T cell responses after a third dose of SARS-CoV-2 vaccine in kidney transplant recipients
E Schrezenmeier, H Rincon-Arevalo… - Journal of the …, 2021 - journals.lww.com
Background Accumulating evidence sugges ts solid organ transplant recipients, as opposed
to the general population, show strongly impaired responsiveness toward standard SARS-…
to the general population, show strongly impaired responsiveness toward standard SARS-…
Altered increase in STAT1 expression and phosphorylation in severe COVID‐19
H Rincon‐Arevalo, A Aue, J Ritter… - European journal of …, 2022 - Wiley Online Library
The interferon pathway, a key antiviral defense mechanism, is being considered as a
therapeutic target in COVID‐19. Both, substitution of interferon and JAK/STAT inhibition to limit …
therapeutic target in COVID‐19. Both, substitution of interferon and JAK/STAT inhibition to limit …
Deep Phenotyping of CD11c+ B Cells in Systemic Autoimmunity and Controls
H Rincon-Arevalo, A Wiedemann, AL Stefanski… - Frontiers in …, 2021 - frontiersin.org
Circulating CD11c + B cells are a key phenomenon in certain types of autoimmunity but have
also been described in the context of regular immune responses (ie, infections, vaccination)…
also been described in the context of regular immune responses (ie, infections, vaccination)…
Modulation of B cell activation by extracellular vesicles and potential alteration of this pathway in patients with rheumatoid arthritis
H Rincón-Arévalo, C Burbano, L Atehortúa… - Arthritis Research & …, 2022 - Springer
Background Extracellular vesicles are involved in the intercellular communication of the
immune system. In rheumatoid arthritis (RA), these structures are considered a source of …
immune system. In rheumatoid arthritis (RA), these structures are considered a source of …
Identification and characterization of post-activated B cells in systemic autoimmune diseases
…, A Wiedemann, H Rincon-Arevalo… - Frontiers in …, 2019 - frontiersin.org
Autoimmune diseases (AID) such as systemic lupus erythematosus (SLE), primary Sjögren's
syndrome (pSS), and rheumatoid arthritis (RA) are chronic inflammatory diseases in which …
syndrome (pSS), and rheumatoid arthritis (RA) are chronic inflammatory diseases in which …
Regulatory B cells and mechanisms
H Rincón-Arévalo, CC Sanchez-Parra… - International reviews …, 2016 - Taylor & Francis
Regulatory B cells have gained prominence in their role as modulators of the immune response
against tumors, infectious diseases, and autoimmune diseases, such as systemic lupus …
against tumors, infectious diseases, and autoimmune diseases, such as systemic lupus …
Plasmablast‐like Phenotype Among Antigen‐Experienced CXCR5–CD19low B Cells in Systemic Lupus Erythematosus
…, E Schrezenmeier, H Rincon‐Arevalo… - Arthritis & …, 2022 - Wiley Online Library
Objective Altered composition of the B cell compartment in the pathogenesis of systemic lupus
erythematosus (SLE) is characterized by expanded plasmablast and IgD–CD27– double‐…
erythematosus (SLE) is characterized by expanded plasmablast and IgD–CD27– double‐…